Moderna, Inc. , a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally.
Moderna stock last closed at $25.13, up 1.68% from the previous day, and has decreased 75.94% in one year. It has overperformed other stocks in the Biotechnology industry by 0.02 percentage points. Moderna stock is currently +8.55% from its 52-week low of $23.15, and -85.26% from its 52-week high of $170.47.
There are currently 385.82M MRNA shares outstanding. The market value of MRNA is $9.70B. In the past 24 hours, 6.84M MRNA shares were traded.
How to Buy Moderna Stock
Not sure how to invest in Moderna stock? Here's how.
Decide where to buy Moderna stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you determine where to buy Moderna stock.
Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Fund your investment account: Select your payment method and add your information.
Research Moderna stock: The Moderna ticker symbol is MRNA. Is Moderna stock a good investment? Should you buy shares of MRNA? How do MRNA's underlying business fundamentals look? Do top analysts think Moderna is a good buy? Why has MRNA's stock price moved recently? (Hint: Our stock market research website can help you figure out if MRNA is a good stock to buy).
Make your MRNA purchase: Decide if you will purchase MRNA shares at the current market price or use a limit order to buy MRNA shares at a given price.
Track your MRNA investment: Create a watchlist to keep track of your position in Moderna shares.
Step 1: Decide where to buy Moderna stock
You will need a brokerage account to access the NASDAQ market and buy MRNA stock.
A brokerage account allows you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to global markets: From Technology to Financial Services, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by creating an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open a brokerage account
Now that you've picked the best brokerage, the next step is to fill out some personal info so you can buy MRNA today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Moderna stock
Once you have chosen the best place to buy Moderna stock, it's important to analyze their stock before you invest, so you actually comprehend the risk as well as the opportunity.
Moderna quick stats
MRNA Price
$25.13
1w %
-6.23%
1y %
-75.94%
5y %
-48.98%
P/E
-2.71x
P/B
0.89x
P/S
2.98x
PEG
N/A
Revenue
$3.24B
Earnings
-$3.56B
Fore. Rev. Growth
5.69%
Fore. Earn. Growth
N/A
Market Cap
$9.70B
Next Earnings
Apr 30, 2025
Next Dividend
N/A
Moderna Fundamentals
WallStreetZen was built to help part-time investors do better fundamental analysis quickly.
There are more short-term assets than long-term liabilities on the MRNA balance sheet.
MRNA has cash burn of 4055000000. It has enough cash and short-term investments to cover this for at least one year.
Total MRNA debt is lower than 5 years ago, relative to shareholder equity.
There are more short-term assets than short-term liabilities on the MRNA balance sheet.
MRNA has a low debt to equity ratio of 0.3.
MRNA has $7.03B in cash and short term investments. This is enough to cover its annual cash burn of $4.06B.
Failed Financial Due Diligence Checks:
MRNA profit margin has gone down from -68.8% to -110% in the past year.
Is it a good time to buy MRNA stock, according to Wall Street analysts?
Out of 12 sell side analysts who research MRNA, the consensus analyst rating on Moderna is a Hold
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
Most Recent MRNA Analyst Upgrades/Downgrades
Gena Wang, a bottom 5% analyst from Barclays downgrades MRNA to a hold rating and lowers their MRNA price target from $111.00 to $45.00, on Feb 18, 2025.
Tim Anderson, a top 31% analyst from Bank of America maintains MRNA with a sell rating and lowers their MRNA price target from $41.00 to $34.00, on Feb 11, 2025.
Salveen Richter, a bottom 14% analyst from Goldman Sachs downgrades MRNA to a hold rating and lowers their MRNA price target from $99.00 to $51.00, on Jan 29, 2025.
Cory Kasimov, a top 22% analyst from Evercore ISI Group maintains MRNA with a hold rating and lowers their MRNA price target from $60.00 to $50.00, on Jan 27, 2025.
Edward Tenthoff, a bottom 2% analyst from Piper Sandler reiterates MRNA with a strong buy rating and lowers their MRNA price target from $115.00 to $69.00, on Nov 18, 2024.
You can dig deeper into what analysts are forecasting on the Moderna stock forecast page.
MRNA Momentum
SMA10
25.57
SMA20
27.63
SMA50
31.07
SMA100
35.76
SMA200
55.96
MACD
-2.04
MACD Signal
-2.06
MACD Histogram
0.02
RSI
38.42
Stochastic %K
27.85
Stochastic %D
28.13
StochRSI %K
67.21
StochRSI %D
70.55
Is MRNA Making Money?
Last year, MRNA revenue was $3.24B. Over the past 5 year, MRNA's revenue has grown by 122.01% per year. This was faster than the Biotechnology industry average of 44.31%.
No, Moderna doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Make your MRNA purchase
You have two primary types of orders:
Market order: A market order is an order to buy or sell a security at the best available price. Market orders are generally sufficient.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at an exact price, use a limit order.
Click the Open button and your broker will place your order.
If you want additional assistance buying stocks on eToro, click the how to video below:
As of Apr 21, 2025, it costs $25.13 to buy one share of Moderna stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.398 shares of MRNA.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.